The Alzheimer’s Disease Cooperative Study (ADCS) was formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California, San Diego. The ADCS is a major initiative for Alzheimer’s disease (AD) clinical studies in the Federal Government, addressing treatments for both cognitive and behavioral symptoms. The ADCS is part of the NIA Division of Neuroscience’s effort to facilitate the discovery, development and testing of new drugs for the treatment of AD and is part of the Alzheimer’s Disease Prevention Initiative as well.
Participate in the BenfoTeam Study
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.
Participate in the BenfoTeam Study
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.
Participate in the BenfoTeam Study
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
The BenfoTeam clinical trial is taking place in approximately 40+ clinical trial sites in the U.S.
BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.
CURRENT ADCS STUDIES & PROGRAMS
BenfoTeam Study
The BenfoTeam Study tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) and mild dementia.
VR Study
Virtual Reality Brain Health Study is a novel study that uses three methods of lifestyle intervention involving physical exercise and Virtual Reality to promote brain health and cognition in older adults which takes place in San Diego, California.
Epstein Family Alzheimer’s Research Collaboration Programs
The Powder for Pennies (P4P) Program aims to create a unique incubator and screening platform to test an array of single and combinatorial repurposed medicines and natural products in clinical trials for the treatment and prevention of AD.
The goal of the Gene Therapy Program (GTP) is to achieve a successful gene therapy treatment for Alzheimer’s disease in people living with the Jalisco PSEN1 mutation.